期刊文献+

肿瘤坏死因子相关凋亡诱导配体诱导结肠癌HCT-116细胞凋亡和炎性反应相关基因表达的研究

Study of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic and inflammatory gene expressions in colon cancer cell line
原文传递
导出
摘要 目的探讨肿瘤坏死因子相关凋亡诱导配体(TRAIL)对结肠癌细胞凋亡和炎性反应相关基因表达的影响。方法HCT-116细胞经10μg/L和100μg/L重组人类TRAIL蛋白处理后,应用荧光实时定量PCR和试剂盒测定凋亡相关基因(Bcl-2、Bad、caspase-3和-8)和炎性反应相关基因(TNF—α,IL-1β,COX-2)的表达水平。结果经10μg几和100μg/L重组人类TRAIL蛋白孵育处理24h后.HCT-116细胞的凋亡率分别为27.4%和45.9%。同时抗凋亡基因Bcl-2、促凋亡基因Bad以及凋亡指示基因caspase-3和caspase-8的表达均显著上调。且100μg/L组的上调幅度均高于10μg/L组(P〈0.05)。TRAIL蛋白处理后,炎性反应相关基因TNF-α,IL-1β,COX-2的表达亦显著上升.且100μg/L处理组的上升幅度均高于10μg/L组(P〈0.05)。结论TRAIL重组蛋白能够诱导结肠癌细胞凋亡以及炎性反应的发生。 Objective To study the effect of recombinant tumor necrosis factor-related apoptosis-indueing ligand (TRAIL) on the expression of apoptosis and inflammatory related genes in human colon cancer cell line HCT-116. Methods After 24-hour treatment with recombinant human TRAIL protein, the expressions of apoptosis-related genes (Bcl-2, Bad, caspase-3, and caspase-8) and inflammation-related genes (TNF-α,IL-1β,and COX-2) were measured by real-time PCR and appropriate kits in HCT-116. Results After treatments of 10 μg/L and 100 μg/L recombinant human TRAIL proteins, the apoptotic rates of HCT-116 cells were 27.4% and 45.9%,respectively. Expressions of anti-apoptosis gene Bcl-2, pro-apoptosis gene Bad and apoptotic markers caspase-3 and caspase-8 were significantly up-regulated, which was more significant in the group of 100 μg/L treatment(P〈0.05 ). Moreover, after TRAIL treatments, expressions of inflammation-related genes TNF-α, IL-1β, COX-2 were also dramatically increased, and 100 μg/L treatment group showed higher up-regulation(P〈0.05). Conclusions Recombinant TRAIL protein induces both apoptosis and inflammation of human colon cancer cells.
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第10期803-806,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 结肠肿瘤 HCT-116 肿瘤坏死因子相关凋亡诱导配体 凋亡 炎性反应 Colonic neoplasms HCT-116 Tumor necrosis factor-related apoptosis-inducing ligand Apoptosis Inflammation
  • 相关文献

参考文献7

  • 1Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Eng J Med, 2009,361 (25) : 2449-2460.
  • 2Hersh EM, Metch BS, Muggia FM, et al. Phase Ⅱ studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience. J Immunother, 1991,10(6):426-431.
  • 3Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer, 2002,2 (6) : 420-430.
  • 4Kischkel FC, Lawrence DA, Chuntharapai A, el al. Apo2L/ TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 2000,12 (6) : 611-620.
  • 5Bodmer JL, Holler N, Reynard S, et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol, 2000,2(4) : 241-243.
  • 6Finnberg N, El-Deity WS. Selective TRAIL-Induced apoptosis in dysplastic neoplasia of the colon may lead to new neoadjuvant or adjuvant therapies. Clin Cancer Res, 2006,12(14):4132- 4136.
  • 7Portt L, Norman G, Clapp C, et al. Anti-apoptosis and cell survival: a review. Biochim Biophys Acta, 2011,1813 (1) : 238-259.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部